
PharmEasy
Launched in 2015, PharmEasy is a consumer healthcare “super app.” Started with the sole purpose of making healthcare accessible and affordable to all, today PharmEasy is India's leading and most trusted online healthcare aggregator in the country. We provide on-demand, home-delivered access to a wide range of prescription pharmaceuticals, diagnostic test services, OTC pharmaceuticals, other consumer healthcare products, thereby serving your healthcare needs. Thus, through our services, we ensure you get access to the best and most genuine health products, with the highest savings in the shortest time possible. Today, we deliver medicines in 1000+ cities in India, covering 19000+ pin codes. We offer diagnostic test services across Mumbai, including Thane, Navi Mumbai, Kalyan & Dombivali, Delhi with Noida, Gurgaon, Faridabad & Ghaziabad, Chennai, Pune, Ahmedabad, and Gandhi Nagar, Surat, Vadodara, Lucknow, Kolkata, Hyderabad, Bengaluru, and Jaipur. We’re proud to be Great Place to Work®…
Overview
PharmEasy is a health tech startup offering services such as teleconsultation, medicine deliveries, and diagnostic test sample collections. It also operates an online pharmacy that helps patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. The startup company is funded and backed by Caisse de Dépôt et Placement du Québec (CDPQ), Ascent Health, Bessemer Venture Partners, Orios Venture Partners, Eight Roads Ventures, InnoVen Capital, and Temasek Holdings. PharmEasy was founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health.
Tech Stack
Funding History
Series D
$220.0M
Nov 2019
Series E
$390.0M
Apr 2021
Secondary Market
$20.0M
Jun 2021
Series F
$500.0M
Jul 2021
Venture Round
$204.0M
Oct 2021
Venture Round
Undisclosed
Oct 2021
Debt Financing
Undisclosed
Nov 2022
Private Equity Round
Undisclosed
Jan 2024
Private Equity Round
$216.2M
Apr 2024
360 ONE Asset, Prosus Ventures
Debt Financing
$193.4M
Sep 2025
Micro Labs, Bennett Coleman and Co Ltd, Mahalaxmi Trust +5